Hummer Financial Advisory Services’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Hold |
1,410
| – | – | 0.16% | 109 |
|
|
2025
Q1 | $222K | Hold |
1,410
| – | – | 0.18% | 100 |
|
|
2024
Q4 | $221K | Hold |
1,410
| – | – | 0.18% | 102 |
|
|
2024
Q3 | $250K | Hold |
1,410
| – | – | 0.2% | 92 |
|
|
2024
Q2 | $237K | Hold |
1,410
| – | – | 0.21% | 94 |
|
|
2024
Q1 | $235K | Hold |
1,410
| – | – | 0.19% | 95 |
|
|
2023
Q4 | $233K | Hold |
1,410
| – | – | 0.21% | 89 |
|
|
2023
Q3 | $220K | Hold |
1,410
| – | – | 0.22% | 90 |
|
|
2023
Q2 | $220K | Buy |
+1,410
| New | +$220K | 0.22% | 90 |
|
|
2023
Q1 | – | Sell |
-1,360
| Closed | -$217K | – | 85 |
|
|
2022
Q4 | $217K | Buy |
+1,360
| New | +$217K | 0.24% | 87 |
|
|
2022
Q3 | – | Sell |
-1,410
| Closed | -$206K | – | 87 |
|
|
2022
Q2 | $206K | Hold |
1,410
| – | – | 0.23% | 92 |
|
|
2022
Q1 | $229K | Buy |
1,410
+200
| +17% | +$32.5K | 0.21% | 94 |
|
|
2021
Q4 | $229K | Sell |
1,210
-200
| -14% | -$37.9K | 0.19% | 93 |
|
|
2021
Q3 | $285K | Hold |
1,410
| – | – | 0.26% | 84 |
|
|
2021
Q2 | $284K | Hold |
1,410
| – | – | 0.26% | 83 |
|
|
2021
Q1 | $247K | Hold |
1,410
| – | – | 0.24% | 89 |
|
|
2020
Q4 | $239K | Hold |
1,410
| – | – | 0.25% | 87 |
|
|
2020
Q3 | $229K | Hold |
1,410
| – | – | 0.27% | 82 |
|
|
2020
Q2 | $230K | Buy |
+1,410
| New | +$230K | 0.29% | 78 |
|